Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
146.15
-5.43 (-3.58%)
At close: Oct 30, 2026, 4:00 PM EDT
148.00
+1.85 (1.27%)
After-hours: Oct 30, 2026, 7:30 PM EDT
Palvella Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho Securities | Mizuho Securities | Buy Maintains $240 → $232 | Buy | Maintains | $240 → $232 | +58.74% | Oct 29, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $210 | Buy | Maintains | $210 | +43.69% | Oct 22, 2026 |
| Clear Street | Clear Street | Buy Maintains $220 | Buy | Maintains | $220 | +50.53% | Oct 20, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $246 | Buy | Reiterates | $246 | +68.32% | Oct 20, 2026 |
| Raymond James | Raymond James | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Oct 16, 2026 |
| William Blair | William Blair | Buy Initiates $266 | Buy | Initiates | $266 | +82.00% | Oct 16, 2026 |
| BTIG | BTIG | Buy Maintains $215 | Buy | Maintains | $215 | +47.11% | Oct 12, 2026 |
| Chardan Capital | Chardan Capital | Buy Maintains $240 | Buy | Maintains | $240 | +64.21% | Sep 21, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.